Found: 38
Select item for more details and to access through your institution.
Impact of Levofloxacin for the Prophylaxis of Bloodstream Infection on the Gut Microbiome in Patients With Hematologic Malignancy.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 7, p. N.PAG, doi. 10.1093/ofid/ofz252
- By:
- Publication type:
- Article
Brentuximab Vedotin for Relapsed or Refractory Sézary Syndrome.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Treatment of CD30-Negative Refractory Mycosis Fungoides With Brentuximab Vedotin.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Effect of malnutrition-driven nutritional support protocol on clinical outcomes in autologous stem cell transplantation patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Fimepinostat (CUDC‐907) in patients with relapsed/refractory diffuse large B cell and high‐grade B‐cell lymphoma: report of a phase 2 trial and exploratory biomarker analyses.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 2, p. 201, doi. 10.1111/bjh.17730
- By:
- Publication type:
- Article
Poor outcomes for double‐hit lymphoma patients treated with curative‐intent second‐line immunochemotherapy following failure of intensive front‐line immunochemotherapy.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 2, p. 313, doi. 10.1111/bjh.16319
- By:
- Publication type:
- Article
Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable.
- Published in:
- British Journal of Haematology, 2016, v. 175, n. 4, p. 631, doi. 10.1111/bjh.14282
- By:
- Publication type:
- Article
Nelarabine, cyclosphosphamide and etoposide for adults with relapsed T-cell acute lymphoblastic leukaemia and lymphoma.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 2, p. 332, doi. 10.1111/bjh.13771
- By:
- Publication type:
- Article
Front-line, dose-escalated immunochemotherapy is associated with a significant progression-free survival advantage in patients with double-hit lymphomas: a systematic review and meta-analysis.
- Published in:
- British Journal of Haematology, 2015, v. 170, n. 4, p. 504, doi. 10.1111/bjh.13463
- By:
- Publication type:
- Article
'Double-Hit' cytogenetic status may not be predicted by baseline clinicopathological characteristics and is highly associated with overall survival in B cell lymphoma patients.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 3, p. 369, doi. 10.1111/bjh.12901
- By:
- Publication type:
- Article
Could treatment with R- HCVAD/ R- MA as compared to R- CHOP truly result in improved outcomes for patients with high-risk diffuse large B cell lymphoma?
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 1, p. 145, doi. 10.1111/bjh.12702
- By:
- Publication type:
- Article
Patterns of immune checkpoint protein expression in MYC-overexpressing aggressive B-cell non-Hodgkin lymphomas.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 869, doi. 10.1007/s00262-020-02708-3
- By:
- Publication type:
- Article
Prevalence and Prognostication of CD5+ Mature T-Cell Lymphomas.
- Published in:
- Cancers, 2024, v. 16, n. 19, p. 3430, doi. 10.3390/cancers16193430
- By:
- Publication type:
- Article
Adult nodular lymphocyte‐predominant Hodgkin lymphoma: treatment modality utilization and survival.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 4, p. 1118, doi. 10.1002/cam4.1383
- By:
- Publication type:
- Article
Melphalan/Total body irradiation-conditioned myeloablative allogeneic hematopoietic cell transplantation for patients with primary plasma cell leukemia.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Outcomes of Tisagenlecleucel in Lymphoma Patients With Predominant Management in an Ambulatory Setting.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. e730, doi. 10.1016/j.clml.2022.04.012
- By:
- Publication type:
- Article
Real World Outcomes in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma Receiving Palliative Intent Therapies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Ibrutinib-associated Arthralgias/Myalgias in Patients With Chronic Lymphocytic Leukemia: Incidence and Impact on Clinical Outcomes.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma With Venetoclax: A Single-Center Evaluation of Off-Label Use.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Nutrition-Related Outcomes for Autologous Stem Cell Transplantation Patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Can We Exploit the Molecular Heterogeneity of Aggressive B Cell Lymphomas Into Effective New Therapies?
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Bexarotene in Patients With Peripheral T-cell Lymphomas: Results of a Retrospective Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Interim PET/CT Result Is Not Predictive of Survival in Patients With MYC-rearranged Non-Burkitt Aggressive B-cell Lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Durable Responses Achieved in Patients with MYC-Altered Relapsed/Refractory Diffuse Large B-cell Lymphoma Treated with Fimepinostat (CUDC-907): Combined Results from a Phase 1 and Phase 2 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S279, doi. 10.1016/j.clml.2018.07.209
- By:
- Publication type:
- Article
Mogamulizumab Multimodality Therapy with Systemic Retinoids, Interferon, or Extracorporeal Photopheresis for Advanced Cutaneous T-Cell Lymphoma.
- Published in:
- Dermatologic Therapy, 2023, p. 1, doi. 10.1155/2023/7625926
- By:
- Publication type:
- Article
Efficacy and safety of bendamustine for lymphodepletion before lisocabtagene maraleucel.
- Published in:
- Journal of Hematology & Oncology, 2024, v. 17, n. 1, p. 1, doi. 10.1186/s13045-024-01542-9
- By:
- Publication type:
- Article
Small-Molecule Inhibitors for the Treatment of Diffuse Large B Cell Lymphoma.
- Published in:
- Current Hematologic Malignancy Reports, 2018, v. 13, n. 5, p. 356, doi. 10.1007/s11899-018-0467-5
- By:
- Publication type:
- Article
Deletion 20q12 is associated with histological transformation of nodal marginal zone lymphoma to diffuse large B‐cell lymphoma.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 3, p. 238, doi. 10.1002/ajh.25694
- By:
- Publication type:
- Article
Outcomes of patients with relapsed/refractory Hodgkin lymphoma progressing after autologous stem cell transplant in the current era of novel therapeutics: A retrospective analysis.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 9, p. 879, doi. 10.1002/ajh.24792
- By:
- Publication type:
- Article
Autologous stem cell transplantation in first complete remission may not extend progression-free survival in patients with peripheral T cell lymphomas.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 7, p. 672, doi. 10.1002/ajh.24372
- By:
- Publication type:
- Article
Receipt of maintenance therapy is most predictive of survival in older acute lymphoblastic leukemia patients treated with intensive induction chemotherapy regimens.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 8, p. 657, doi. 10.1002/ajh.23468
- By:
- Publication type:
- Article
"DO YOU HAVE AN ADVANCE DIRECTIVE?": A COLLABORATION BETWEEN NURSES AND SOCIAL WORK TO INCREASE ADVANCE DIRECTIVE DOCUMENTATION.
- Published in:
- Oncology Nursing Forum, 2022, v. 49, n. 2, p. E127, doi. 10.1188/22.ONF.E2
- By:
- Publication type:
- Article
Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: A report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 16, p. 2464, doi. 10.1002/cncr.28712
- By:
- Publication type:
- Article
Outcomes and Toxicities of Programmed Death‐1 (PD‐1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Real‐World, Multicenter Retrospective Analysis.
- Published in:
- Oncologist, 2019, v. 24, n. 7, p. 955, doi. 10.1634/theoncologist.2018-0538
- By:
- Publication type:
- Article
Hodgkin lymphoma patients have an increased incidence of idiopathic acquired aplastic anemia.
- Published in:
- PLoS ONE, 2019, v. 14, n. 4, p. 1, doi. 10.1371/journal.pone.0215021
- By:
- Publication type:
- Article
Immunologic Predictors of Vaccine Responsiveness in Patients With Lymphoma and Chronic Lymphocytic Leukemia.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 1, p. 15, doi. 10.1093/infdis/jiae106
- By:
- Publication type:
- Article
Management of Patients with MYC-Altered Lymphomas.
- Published in:
- Current Hematologic Malignancy Reports, 2016, v. 11, n. 3, p. 208, doi. 10.1007/s11899-016-0320-7
- By:
- Publication type:
- Article